Features of Interferon and Cytokine Status in Atopic Dermatitis

Authors

  • Ospelnikova TP Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098
  • Gevorkyan OV Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098
  • Mironova TV Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098
  • Andreeva SA Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098
  • Kolodyazhnaya LV Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098
  • Ershov FI Federal State Budgetary Institution, “Federal Research Centre of Epidemiology and Microbiology named after the Honorary Academician N.F.Gamaleya” of the Ministry of Health of the Russian Federation, Gamaleya Street, 18, Moscow, Russian Federation, 123098

DOI:

https://doi.org/10.29328/journal.aaai.1001002

Keywords:

Atopic dermatits, Cytokines, Herpes virus, Interferon inducer Cycloferon, ELISA

Abstract

The insufficiency of interferon production and the cytokine imbalance in patients with atopic dermatitis, especially in combination with persistent herpes virus infection, has been identified. The expediency of the use of interferon inducer Cycloferon in the treatment of chronic atopic dermatitis has been shown.

References

Corren J. Inflammatory Disorders Associated with Allergy: Overview of Immunopathogenesis and Implications for Treatment. Immunol Allergy Clin North Am. 2017; 37: 233-246. Ref.: https://goo.gl/sJp55z

Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014; 71: 116-132. Ref.: https://goo.gl/VKCCdO

Ong PY, Leung DY. Atopic dermatitis. Clin Allergy Immunol. 2002; 16: 355-379. Ref.: https://goo.gl/CSE6rP

Ohshima Y, Yamada A, Hiraoka M, Katamura K, Ito S, et al. Early sensitization to house dust mite is a major risk factor for subsequent development of bronchial asthma in Japanese infants with atopic dermstitis: results of a 4-year followup study. Ann Allergy Asthma Immunol. 2002; 89: 265-270. Ref.: https://goo.gl/Dt9mSx

Krakowski AC, Eichenfield LF, Dohil MA. Management of atopic dermatitis in the pediatric population. Pediatrics. 2008; 122: 812-824. Ref.: https://goo.gl/UvI7RF

Hanifin JM, Cooper KD, Ho VC, Sewon K, Bernice RK, et al. Guidelines of care for atopic dermstitis. J Am Acad Dermatol. 2004; 50: 391-404. Ref.: https://goo.gl/eLCGe4

Maintz L, Novak N. Modifications of the innate immune system in atopic dermatitis. J Innate Immun. 2011; 3: 131-141. Ref.: https://goo.gl/fjIPwn

Zeiger RS, Heller S, Mellon MH, Forsythe AB, O'Connor RD, et al. Effect of combined maternal and infant food-allergen avidance on development of atopy in early infancy: a randomized study. J Allergy Clin Immunol. 1989; 84: 72-89. Ref.: https://goo.gl/PE8xyl

Imai Y, Nakada A, Hashida R, Sugita Y, Tanaka T, et al. Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients. Biochem and Biophys Res Commun. 2002; 297: 1282-1290. Ref.: https://goo.gl/4WYYE5

Valenta R, Kraft D. From allergen structure to new forms of allergen-specific immunotherapy. Current Opin Immunol. 2002; 14: 718-727. Ref.: https://goo.gl/P8qy4K

Ospelnikova TP, Konisheva AV, Mazurina SA, Lyzogub NV, Osipova VV. Evaluation of interferon system and the main cytokines in patients with bronchial asthma. J Microbiol, Epidemiol, Immunol. 2012; 1: 35-41. Ref.: https://goo.gl/DnkLld

Ong PY, Leung DY. Bacterial and Viral Infections in Atopic Dermatitis: a Comprehensive Review. Clin Rev Allergy Immunol. 2016; 51: 329-337. Ref.: https://goo.gl/YCC5Cz

Ershov FI, Ospelnikova TP Modern arsenal of antiherpetic drugs. Infections and Antimicrobial Therapy. 2001; 4: 100-104.

Simbirtsev AS. Cytokines: classification and biological functions. Cytokines and inflammation. 2004; 2: 16-23. Ref.: https://goo.gl/s08PNm

O’Shea JJ, Averil М, Lipsky Р. Cytokines and autoimmunity. Naturе Reviews Immunology. 2002; 2: 37-45. Ref.: https://goo.gl/Qncl40

Downloads

Published

2017-05-29

How to Cite

TP, O., OV, G., TV, M., SA, A., LV, K., & FI, E. (2017). Features of Interferon and Cytokine Status in Atopic Dermatitis. Archives of Asthma, Allergy and Immunology, 1(1), 009–014. https://doi.org/10.29328/journal.aaai.1001002

Issue

Vol. 1 No. 1 (2017)

Section

Research Articles

Categories

License

Copyright (c) 2017 Ospelnikova TP, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Similar Articles

You may also start an advanced similarity search for this article.